| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 110,318 | 113,243 | 110,143 | 122,487 | | Cost of Revenue | 84,669 | 88,914 | 88,416 | 98,168 | | | Gross Profit | 25,649 | 24,329 | 21,727 | 24,319 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,983 | 18,945 | 18,550 | 20,541 | | Non Recurring |
-
|
-
|
-
| 5,010 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,666 | 5,384 | 3,177 | (1,232) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 149 | 113 | 205 | 820 | | Earnings Before Interest And Taxes | 21,087 | (7,775) | 3,382 | (412) | | Interest Expense | 1,005 | 1,147 | 1,096 | 1,702 | | Income Before Tax | 20,082 | (8,922) | 2,286 | (2,114) | | Income Tax Expense | 2,227 | 1,358 | 743 | (263) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,583 | 2,992 | 1,543 | (1,851) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,583 | 2,992 | 1,543 | (1,851) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,583 | $2,992 | $1,543 | ($1,851) |
|
0.31% Nasdaq 0.00%
Income Statement
